FDA approves thalidomide-like drug for rare bone marrow disorders

WASHINGTON (CP) - A drug similar to one that causes birth defects has won FDA approval to treat anemia in people who suffer from certain kinds of rare bone-marrow disorders known as myelodysplastic syndromes, or MDS. The U.S....More